Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways

Endovia has secured financing as the FDA and Congress increase their focus on advancing and incentivizing regulated development of botanical and plant-derived medicines. The funding and supportive policy attention are modestly positive for Endovia and the regulated plant-derived therapeutics sector, although no financing amount or commercial milestones were disclosed.